David Bharucha - Jan 27, 2025 Form 4 Insider Report for Milestone Pharmaceuticals Inc. (MIST)

Role
Chief Medical Officer
Signature
/s/ Jason Minio, Attorney-in-Fact
Stock symbol
MIST
Transactions as of
Jan 27, 2025
Transactions value $
$0
Form type
4
Date filed
1/29/2025, 04:15 PM
Previous filing
Feb 17, 2023
Next filing
Jul 15, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MIST Employee Stock Option (right to buy) Award $0 +121K $0.00 121K Jan 27, 2025 Common Shares 121K $2.02 Direct F1
transaction MIST Restricted Stock Unit Award $0 +80.4K $0.00 80.4K Jan 27, 2025 Common Shares 80.4K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One-fourth (1/4th) of the shares subject to the option vest on Jaunary 27, 2026, and one thirty-sixth (1/36th) of the remaining shares subject to this option shall vest each month thereafter, subject to the Reporting Person continuing to provide service through each such date.
F2 Each restricted stock unit represents a contingent right to receive one common share.
F3 One-fourth (1/4th) of the shares subject to the restricted stock unit award vest on each of Jaunary 27, 2026, Jaunary 27, 2027, Jaunary 27, 2028 and Jaunary 27, 2029, subject to the Reporting Person continuing to provide service through each such date.